Publications by authors named "Bob Li"

Claim this Profile
R
Risk and Outcomes of Secondary Cancer Among Lung Cancer Survivors After Definitive Treatment.
Matthew T McMillan, Orly Yariv, Sana Raoof, Jamie E Chaft, Bernard J Park, Julianne Ruggiero, Bob T Li

JAMA Netw Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Deruxtecan for ERBB2-Mutant Metastatic Non-Small Cell Lung Cancer With or Without Brain Metastases: A Secondary Analysis of Randomized Clinical Trials.
Pasi A Jänne, David Planchard, Koichi Goto, Egbert F Smit, Adrianus Johannes de Langen, Enriqueta Felip, Kaline Pereira, Ahmed Ali, Bob T Li

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies.
Bob T Li, Leena Gandhi, Vignesh Ravichandran, Benjamin Besse, Julien Mazières, Elisabeth Quoix, Lisa D Eli, David B Solit

Clin Lung Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomic phenotypes of oligometastatic non-small cell lung cancer.
Kevin M Boehm, Emily S Lebow, N Ari Wijetunga, Justin Haseltine, Andreas Rimner, Bob T Li

Transl Lung Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrocyclic Ruthenium Ring Expansion Metathesis Polymerization Initiators Exhibit Tether Length-Dependent Behavior.
Meredith N Pomfret, Lucy P Miller, Nicholas P Serck, Ángel Rentería-Gómez, Bob Li

Organometallics· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants of sotorasib clinical efficacy in KRAS-mutated non-small-cell lung cancer.
Ferdinandos Skoulidis, Bob T Li, Adrianus Johannes de Langen, David S Hong, Herve Lena, Colin R Lindsay

Nat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial Disease Control and Survival among Patients with KRAS-mutant Lung Adenocarcinoma and Brain Metastases Treated with Stereotactic Radiosurgery.
Benjamin Gaeta, Jordan E Eichholz, Henry Walch, Ahmet T Ilica, Lillian Boe, Bob T Li

Int J Radiat Oncol Biol Phys· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ultrasensitive method for detection of cell-free RNA.
Monica C Nesselbush, Bogdan A Luca, Young-Jun Jeon, Isabel Jabara, Catherine B Meador, William Y Shi, Kevin J Liu, Chih Long Liu, Alice Jiang, Tyler Raclin, Bob T Li, Ash A Alizadeh, Maximilian Diehn

Nature· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors.
Dazhi Liu, Justin Jee, Alexander Drilon, Andreas M Heilmann, Justin M Allen, Bob T Li

Cancer Res Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Free Circulating Tumor DNA for NonInvasive Molecular Profiling Among Patients Undergoing Definitive Chemoradiation for Locally Advanced Lung Cancer.
Emily S Lebow, Jordan Eichholz, Lillian Boe, Zhigang Zhang, Leah B Kratochvil, Bob T Li

Adv Radiat Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies.
Daniel Reinhorn, Mor Moskovitz, William D Tap, Bob T Li

Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer.
Ferdinandos Skoulidis, Bob T Li, Maximilian Hochmair, Ramaswamy Govindan, Mark Vincent, Simon Häfliger, Colin Lindsay, Giulia Pasello, William Kormany

Oncologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated real-world data integration improves cancer outcome prediction.
Justin Jee, Christopher Fong, Karl Pichotta, Thinh Ngoc Tran, Anisha Luthra, Chenlian Fu, Si-Yang Liu, Walid K Chatila, David Liu, Lisa Loudon, Lior Braunstein, Anyi Li, David B Solit, Julio Garcia-Aguilar, Bob T Li

Nature· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR-directed antibodies promote HER2 ADC internalization and efficacy.
Avantika Gupta, Flavia Michelini, Hong Shao, Celine Yeh, Joshua Z Drago, Dazhi Liu, Elisa de Stanchina, Bob T Li

Cell Rep Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial.
Erika P Hamilton, Gerald S Falchook, Judy S Wang, Siqing Fu, Amit M Oza, Bob T Li

Target Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waiting to Exhale: The Feasibility and Appropriateness of Home Blood Oxygen Monitoring in Oncology Patients Post-Hospital Discharge.
Si-Yang Liu, Sahil D Doshi, AnnMarie Mazzella Ebstein, Jessie Holland, Ayelet Sapir, Bob Li

JCO Clin Cancer Inform· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer.
Si-Yang Liu, Tatiana Erazo, Justin Jee, Andrea Arfe, Avantika Gupta, Kaylie Johnson, William Travis, Bob T Li

Eur J Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Promising Step Forward With Giant Leaps Ahead.
Narek Shaverdian, Bob T Li, James Isbell, Jamie E Chaft

J Thorac Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Genomic Characterization of -Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort.
Sebastián Mondaca, Henry Walch, Santiago Sepúlveda, Nikolaus Schultz, Gonzalo Muñoz, Walid Chatila, Bob Li

JCO Glob Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling lung adenocarcinoma metastases using patient-derived organoids.
Yuan Liu, Manendra Lankadasari, Joel Rosiene, Kofi E Johnson, Juan Zhou, Elizabeth G Dunne, Bob T Li, Piro Lito, Prasad S Adusumilli, Marcin Imielinski

Cell Rep Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: dynamic personalized physiological monitoring in lung cancer using wearable data.
Joshua W Bliss, Whitney P Underwood, Adele M Carlson, Jessica M Scott, Robert Daly, Bob T Li

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer.
Yonina R Murciano-Goroff, Angela B-Y Hui, Jose A Araujo Filho, Emily G Hamilton, Jacob J Chabon, Ash A Alizadeh, Bob T Li, Maximilian Diehn

JCO Precis Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors.
Richard A Hickman, Alexandra M Miller, Bridget M Holle, Justin Jee, Si-Yang Liu, Bob Li, Ingo K Mellinghoff

Acta Neuropathol Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance.
Malinda Itchins, Shirley Liang, Chris Brown, Tristan Barnes, Gavin Marx, Bob T Li

JTO Clin Res Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer.
Anton Safonov, Antonio Marra, Chaitanya Bandlamudi, Ben O'Leary, Bradley Wubbenhorst, Julia An, Natalia Lukashchuk, Yuan Liu, Bob T Li, David B Solit

bioRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis